Skip to nav Skip to content
  • Cancer Type: N/A
  • Study Type: Treatment
  • NCT#: NCT05705401
  • Phase: Phase III
Learn More
  • Overview

    Study Title:

    A Phase III Randomized Trial of Radiotherapy Optimization for Low-Risk Her2-Positive Breast Cancer (HERO*)

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.

Clinical Trial Search